Sartorius (OTCMKTS:SARTF) Sees Significant Increase in Short Interest

Sartorius (OTCMKTS:SARTF) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 1,827 shares, an increase of 282.2% from the September 30th total of 478 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ? days.

Sartorius Stock Performance

Sartorius stock opened at $243.86 on Thursday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.49 and a current ratio of 0.95. The company has a market capitalization of $8.35 billion, a price-to-earnings ratio of 113.42 and a beta of 0.98. Sartorius has a fifty-two week low of $181.58 and a fifty-two week high of $243.86. The stock has a fifty day moving average of $230.16 and a two-hundred day moving average of $221.90.

About Sartorius

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services used in research, pharmaceutical development and biopharmaceutical manufacturing. Its offerings support laboratories and production facilities across the development cycle, from early-stage research and process development to commercial-scale manufacturing.

The company operates through its Lab Products & Services and Bioprocess Solutions divisions. Its products and services include laboratory instruments, balances, consumables, analytical systems, filtration technologies, bioreactors, cell culture equipment, single-use manufacturing components, software and related services.